Alexander Gene Montano
Plus aucun poste en cours
Profil
Mr. Alexander G.
Montano is Chief Executive Officer at C.
K.
Cooper & Co.
Mr. Montano also served on the board at Cubic Energy, Inc. and CardioVascular BioTherapeutics, Inc.
Anciens postes connus de Alexander Gene Montano
| Sociétés | Poste | Fin |
|---|---|---|
C.K. Cooper & Co.
 C.K. Cooper & Co. Investment Banks/BrokersFinance C.K. Cooper & Co. is a full-service investment banking and broker/dealer headquartered in Irvine, California. The firm was founded in 1982 as a wholly-owned subsidiary of C & K Capital Corp., and a sister company to Paladin Capital Partners, Inc. The services provided by C.K. Cooper & Co. were expanded in 1996, when a management team led by Alexander G. Montano purchased the firm. In 2001, C.K. Cooper & Co. began to offer brokerage services to individual investors. The firm is a member of the NASD. C.K. Cooper & Co. focuses on the oil and gas sectors. Their primary focus within the oil and gas sectors is the exploration and production sub-sector. The core thesis of the firm's research is based on what they refer to as the feeding frenzy, suggesting that there are constant business cycles within the E&P sector. These cycles are predicated on the need for larger oil and gas companies to acquire smaller exploration and production companies to maintain rates of growth. | President | 31/12/2009 |
Venturis Therapeutics, Inc.
 Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | Directeur/Membre du Conseil | 01/01/2006 |
| CUBIC ENERGY INC | Directeur/Membre du Conseil | 01/01/2005 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
C.K. Cooper & Co.
C.K. Cooper & Co. Investment Banks/BrokersFinance C.K. Cooper & Co. is a full-service investment banking and broker/dealer headquartered in Irvine, California. The firm was founded in 1982 as a wholly-owned subsidiary of C & K Capital Corp., and a sister company to Paladin Capital Partners, Inc. The services provided by C.K. Cooper & Co. were expanded in 1996, when a management team led by Alexander G. Montano purchased the firm. In 2001, C.K. Cooper & Co. began to offer brokerage services to individual investors. The firm is a member of the NASD. C.K. Cooper & Co. focuses on the oil and gas sectors. Their primary focus within the oil and gas sectors is the exploration and production sub-sector. The core thesis of the firm's research is based on what they refer to as the feeding frenzy, suggesting that there are constant business cycles within the E&P sector. These cycles are predicated on the need for larger oil and gas companies to acquire smaller exploration and production companies to maintain rates of growth. | Finance |
Cubic Energy, Inc.
 Cubic Energy, Inc. Oil & Gas ProductionEnergy Minerals Cubic Energy, Inc. is engaged in the exploration, development and production of oil and natural gas. The company was founded by George W. McDonald and is headquartered in Dallas, TX. | Energy Minerals |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | Commercial Services |
